Multimolecular characteristics and role of BRCA1 interacting protein C-terminal helicase 1 (BRIP1) in human tumors: a pan-cancer analysis. 2023

Ruohuang Wang, and Jisheng Zhang, and Xin Cui, and Shun Wang, and Ting Chen, and Yanfang Niu, and Xiaoyun Du, and Jingwen Kong, and Lin Wang, and Yan Jiang
Department of Otolaryngology-Head and Neck Surgery, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, Shandong, 266000, China.

BACKGROUND The aberrant expression of BRIP1 was associated with several cancers; however, the panoramic picture of BRIP1 in human tumors remains unclear. This study aims to explore the pan-cancerous picture of the expression of BRIP1 across 33 human cancers. METHODS Based on the data from TCGA and GTEx, a series of bioinformatic analyses were applied to systematically explore the genetic landscape and biologic function of BRIP1 in 33 human tumors. RESULTS We observed prognosis-related differential BRIP1 expressions between various carcinomas and the corresponding normal tissues. "Basal transcription factors," "homologous recombination," "nucleotide excision repair," and DNA metabolism pathways may play a role in the functional mechanisms of BRIP1. Patients with uterine corpus endometrial carcinoma presented with the highest alteration frequency of BRIP1 (nearly 10%). Single-nucleotide and copy number variations of BRIP1 were noticed in multiple cancers, and the expression of BRIP1 is significantly regulated by copy number variation in breast invasive carcinoma and lung squamous cell carcinoma. BRIP1 expression is negatively correlated with the DNA methylation levels in many tumors and is associated with the activation of apoptosis, cell cycle, DNA damage response, and inhibition of hormone ER and RNS/MARK signaling pathways. Moreover, a positive correlation was observed between BRIP1 expression and the immune infiltration levels of cancer-associated fibroblasts and CD8+ T cells in lung adenocarcinoma. CONCLUSIONS Our pan-cancer analysis of BRIP1 provides a valuable resource for understanding the multimolecular characteristics and biological function of BRIP1 across human cancers.

UI MeSH Term Description Entries
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002277 Carcinoma A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for "cancer." Carcinoma, Anaplastic,Carcinoma, Spindle-Cell,Carcinoma, Undifferentiated,Carcinomatosis,Epithelial Neoplasms, Malignant,Epithelioma,Epithelial Tumors, Malignant,Malignant Epithelial Neoplasms,Neoplasms, Malignant Epithelial,Anaplastic Carcinoma,Anaplastic Carcinomas,Carcinoma, Spindle Cell,Carcinomas,Carcinomatoses,Epithelial Neoplasm, Malignant,Epithelial Tumor, Malignant,Epitheliomas,Malignant Epithelial Neoplasm,Malignant Epithelial Tumor,Malignant Epithelial Tumors,Neoplasm, Malignant Epithelial,Spindle-Cell Carcinoma,Spindle-Cell Carcinomas,Tumor, Malignant Epithelial,Undifferentiated Carcinoma,Undifferentiated Carcinomas
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D051856 Fanconi Anemia Complementation Group Proteins A diverse group of proteins whose genetic MUTATIONS have been associated with the chromosomal instability syndrome FANCONI ANEMIA. Many of these proteins play important roles in protecting CELLS against OXIDATIVE STRESS. Fanconi Anemia Core Complex Proteins,Fanconi Anemia Proteins,FANC Proteins
D056915 DNA Copy Number Variations Stretches of genomic DNA that exist in different multiples between individuals. Many copy number variations have been associated with susceptibility or resistance to disease. Copy Number Polymorphism,DNA Copy Number Variant,Copy Number Changes, DNA,Copy Number Polymorphisms,Copy Number Variants, DNA,Copy Number Variation, DNA,DNA Copy Number Change,DNA Copy Number Changes,DNA Copy Number Polymorphism,DNA Copy Number Polymorphisms,DNA Copy Number Variants,DNA Copy Number Variation,Polymorphism, Copy Number,Polymorphisms, Copy Number
D020365 RNA Helicases A family of proteins that promote unwinding of RNA during splicing and translation. RNA Helicase,Helicase, RNA,Helicases, RNA

Related Publications

Ruohuang Wang, and Jisheng Zhang, and Xin Cui, and Shun Wang, and Ting Chen, and Yanfang Niu, and Xiaoyun Du, and Jingwen Kong, and Lin Wang, and Yan Jiang
October 2020, Journal of cellular and molecular medicine,
Ruohuang Wang, and Jisheng Zhang, and Xin Cui, and Shun Wang, and Ting Chen, and Yanfang Niu, and Xiaoyun Du, and Jingwen Kong, and Lin Wang, and Yan Jiang
November 2013, Genetics and molecular research : GMR,
Ruohuang Wang, and Jisheng Zhang, and Xin Cui, and Shun Wang, and Ting Chen, and Yanfang Niu, and Xiaoyun Du, and Jingwen Kong, and Lin Wang, and Yan Jiang
September 2005, Nature genetics,
Ruohuang Wang, and Jisheng Zhang, and Xin Cui, and Shun Wang, and Ting Chen, and Yanfang Niu, and Xiaoyun Du, and Jingwen Kong, and Lin Wang, and Yan Jiang
March 2023, Scientific reports,
Ruohuang Wang, and Jisheng Zhang, and Xin Cui, and Shun Wang, and Ting Chen, and Yanfang Niu, and Xiaoyun Du, and Jingwen Kong, and Lin Wang, and Yan Jiang
January 2013, PloS one,
Ruohuang Wang, and Jisheng Zhang, and Xin Cui, and Shun Wang, and Ting Chen, and Yanfang Niu, and Xiaoyun Du, and Jingwen Kong, and Lin Wang, and Yan Jiang
November 1998, Oncogene,
Ruohuang Wang, and Jisheng Zhang, and Xin Cui, and Shun Wang, and Ting Chen, and Yanfang Niu, and Xiaoyun Du, and Jingwen Kong, and Lin Wang, and Yan Jiang
July 2008, Oncogene,
Ruohuang Wang, and Jisheng Zhang, and Xin Cui, and Shun Wang, and Ting Chen, and Yanfang Niu, and Xiaoyun Du, and Jingwen Kong, and Lin Wang, and Yan Jiang
January 2023, Frontiers in oncology,
Ruohuang Wang, and Jisheng Zhang, and Xin Cui, and Shun Wang, and Ting Chen, and Yanfang Niu, and Xiaoyun Du, and Jingwen Kong, and Lin Wang, and Yan Jiang
December 2022, Medicine,
Ruohuang Wang, and Jisheng Zhang, and Xin Cui, and Shun Wang, and Ting Chen, and Yanfang Niu, and Xiaoyun Du, and Jingwen Kong, and Lin Wang, and Yan Jiang
June 2021, Molecular cancer research : MCR,
Copied contents to your clipboard!